The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASLR.L Regulatory News (ASLR)

  • There is currently no data for ASLR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further conditional investment in Dev Clever

1 Dec 2020 07:00

RNS Number : 0196H
Asimilar Group PLC
01 December 2020
 

Asimilar Group Plc

("Asimilar" or the "Company")

 

Further conditional investment in Dev Clever

 

 

Asimilar Group plc (AIM: ASLR), the AIM quoted investment company focused on technology opportunities in the fields of big data, machine learning, telematics and the Internet of Things (IoT), provides an update on its investment in Dev Clever Holdings plc ("Dev Clever").

 

Asimilar's wholly owned subsidiary, Intrinsic Capital (Jersey) Limited ("ICJL"), has conditionally subscribed for 20,000,000 new shares in Dev Clever at a subscription price of 10p per share ("the Subscription Shares"), being the second tranche of its subscription rights to invest in new shares in Dev Clever.

 

ICJL has agreed with Dev Clever to amend the terms of its investment agreement so that completion of the second subscription is conditional on either (1) Dev Clever publishing a prospectus approved by the FCA on or before 25 January 2021; or (2) the issue and admission of the Subscription Shares in respect of the second tranche being exempt from the requirement for publication by Dev Clever of a prospectus.

 

Asimilar currently has an interest in 20 million shares in Dev Clever (representing 4.2% of Dev Clever's issued share capital). On completion of the second subscription, Asimilar would have an interest over 8.1% of Dev Clever's enlarged issued share capital.

 

Dev Clever is listed on the Standard List of the London Stock Exchange. The subscription for the third and fourth investment tranches remains conditional on the publication of a prospectus by Dev Clever.

 

Asimilar is in discussions with Dev Clever about the opportunity to accelerate the two remaining investment tranches, subject to the publication by Dev Clever of a prospectus.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The Directors of the Company take responsibility for this announcement.

 

**ENDS**

Contacts

Asimilar Group plc

John Taylor, Non-Executive Chairman

via Buchanan

Cairn Financial Advisers LLP

Sandy Jamieson / Liam Murray

Tel: +44 20 7213 0880

Peterhouse Capital Limited

Duncan Vasey / Lucy Williams

Tel: + 44 20 7220 9797

Buchanan Communications Limited

Richard Oldworth / Chris Lane

Tel: +44 (0) 20 7466 5000

 

Caution regarding forward looking statements

 

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKKKBQDBDBBDN
Date   Source Headline
18th Nov 20057:01 amRNSPositive Product Test Results
20th Oct 20057:00 amRNSTrading Statement
1st Aug 20059:27 amRNSBoard Appointment
29th Jul 20057:01 amRNSEgypt contract gain
8th Jul 200512:14 pmRNSResult of EGM
29th Jun 20055:30 pmRNSInterim Results
21st Jun 20057:00 amRNSOverseas Contract Gains
15th Jun 20054:03 pmRNSNotice of EGM
15th Jun 20052:21 pmRNSBoard Appointment
10th Jun 20057:00 amRNSOverseas Contract Gains
2nd Jun 20057:01 amRNSUS Collaboration deal
25th May 200512:30 pmRNSIssue of Equity
29th Mar 20051:13 pmRNSAGM Statement
2nd Feb 20054:51 pmRNSFinal Results Replacement
14th Jan 20051:39 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.